Background illustration for clinical trials search

Endocrine Clinical Trials

Browse 341 endocrine clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

FELLAShip to Better Health

for
High Blood Glucose, High Cholesterol,
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: Male

Age: 18+

Code: NCT07220213

Recruiting

Chromosome 18 Clinical Research Center

for
Chromosome Aberrations, Growth Hormone Deficiency,
Location: San Antonio TX
Sponsor: The University of Texas Health Science Center at San Antonio

Sex: All

Age: 0+

Code: NCT00227253

Recruiting

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

for
SST2-positive Neuroendocrine Neoplasms, Neuroendocrine Tumors,
Location: New York NY, Philadelphia PA, Fairfax VA,
Sponsor: Crinetics Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT07129252

Phase1, Phase2, Recruiting

Menstrual Cycle vs. Oral Contraceptives: Effects on Muscle Protein Metabolism After Resistance Exercise

for
Female Sex Hormones, Menstrual Cycle, Oral Contraceptives,
Location: Toronto
Sponsor: University of Toronto

Sex: Female

Age: 18 - 40

Code: NCT07258576

Recruiting

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

for
Cutaneous Squamous Cell Carcinoma,
Location: Uniondale NY, New York NY, Middletown NJ, Montvale NJ,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05859074

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Randomized Stepped Wedge Study of Emapalumab in APECED Enteritis

for
Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy Enteritis,
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 2 - 70+

Code: NCT07202598

Phase2, Recruiting

TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

for
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Location: Montreal, Myrtle Beach SC, Durham NC, Charleston SC,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT07190300

Phase1, Phase2, Recruiting

A Study of Armored CAR T Cells in People With Cancer

for
Neuroendocrine Cancer, Small Cell Lung Cancer,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07783477

Phase1, Recruiting

Charactertizing Growth Hormone Deficiency in Traumatic Brain Injury

for
Growth Hormone Deficiency, Traumatic Brain Injury
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 18 - 70

Code: NCT07795736

Recruiting

Optimal PSA Triggered Individual Management of Androgen Sensitive Prostate Cancer

for
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: Male

Age: 18+

Code: NCT07216248

Phase2, Recruiting

FTT PET/CT in Pancreatic Neuroendocrine Tumors

for
Neuroendocrine Carcinoma Metastatic, Pancreatic Tumors
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 18+

Code: NCT07114939

Phase1, Recruiting

Comparing Acupuncture vs. Sham Acupuncture for the Management of Hot Flashes in Prostate Cancer Patients Receiving Hormone Therapy

for
Accupuncture, Prostate Cancer, Hormone Therapy, Hot Flashes
Location: Lexington KY
Sponsor: University of Kentucky

Sex: All

Age: 18 - 70+

Code: NCT07594002

Recruiting

Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors

for
Small Cell Lung Carcinoma,
Location: Boston MA, Montreal, Royal Oak MI, Iowa City IA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07006727

Phase1, Recruiting

Neuroimaging and Biomarkers of Neurotoxicity After Chimeric Antigen Receptor T-Cell Therapy

for
CAR T-Cell Therapy
Location: La Jolla CA
Sponsor: University of California, San Diego

Sex: All

Age: 18+

Code: NCT07075523

Recruiting

CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes

for
Type 2 Diabetes Mellitus (T2DM), Pregnancy,
Location: Sewell NJ, Philadelphia PA
Sponsor: Thomas Jefferson University

Sex: Female

Age: 18+

Code: NCT07184775

Recruiting

Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma

for
Advanced Or Metastatic Merkel Cell Carcinoma
Location: Boston MA, Hackensack NJ, Morristown NJ, Greenville NC,
Sponsor: TuHURA Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT06947928

Phase2, Phase3, Recruiting

IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC)

for
Advanced Or Metastatic Merkel Cell Carcinoma
Location: Tampa FL, Madison WI
Sponsor: TuHURA Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT06940440

Phase1, Recruiting

Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells

for
Glucose, Metabolism, Isotope Labeling,
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 18+

Code: NCT06930976

Recruiting

DESTINY-PANTUMOUR04

for
Adenocarcinoma (NOS), Anal Cancer, Bladder Cancer,
Location: Philadelphia PA, Wilson NC, Durham NC,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07124000

Recruiting

Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer

for
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Location: Boston MA, Philadelphia PA, Myrtle Beach SC,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT07140900

Phase1, Recruiting